ERBB2 and breast carcinoma: Our study indicated that aspirin exerted an anticancer activity in the HER-2-positive breast cancer cell lines AU-565, BT-474 and SKBR-3 by inhibiting their proliferation and colony-forming abilities, regulating cell cycle progression, and inducing apoptosis, through the activation of AMPK signaling.